Novartis Investigative Site

Nara, Nara 630-8581

0 studies enrolling now · 3 studies all time

What they study most

IgA Nephropathy, Immunoglobulin A Nephropathy, Sarcopenia

Studies at this site

• A Study of Zigakibart in Adults With IgA Nephropathy — Running, not enrolling
• Dose Range Finding Study of Bimagrumab in Sarcopenia — Completed
• A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study — Completed